FMC7 ANTIGEN / EDTA BLOOD

image not found

NABL Cap Accredited     
The FMC7 Antigen test at Metropolis Healthcare is a specialized flow cytometry marker used to differentiate between various types of B-cell lymphoproliferative disorders. It helps classify conditions such as chronic lymphocytic leukemia (CLL) and other B-cell malignancies by identifying specific antigen expression patterns. This test plays a key role in accurate diagnosis and treatment planning. Metropolis Healthcare performs the analysis using advanced flow cytometry platforms for highly reliable immunophenotyping

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,595.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: F0034

Frequently Asked Questions (FAQ's):

What does the FMC7 Antigen test detect?
It identifies FMC7 expression on B-cells to help classify B-cell lymphoproliferative disorders.

Why is FMC7 important in diagnosis?
It helps differentiate CLL from other B-cell malignancies, improving diagnostic accuracy.

How does Metropolis Healthcare perform this test?
Metropolis uses advanced flow cytometry to analyze B-cell antigen expression patterns.

What sample is required?
An EDTA blood sample is used for flow cytometry analysis.

Do I need to fast before the test?
No fasting or special preparation is required.

Who should undergo this test?
Patients being evaluated for suspected B-cell leukemia or lymphoma.

Is FMC7 used along with other markers?
Yes, it is part of a larger immunophenotyping panel for precise classification.

How soon are results available from Metropolis Healthcare?
Results are typically available within a short turnaround time to support timely clinical decisions

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab